RecruitingPhase 3NCT05751967

Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis

Studying Primary biliary cholangitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Xijing Hospital of Digestive Diseases
Principal Investigator: Ying Han, Doctor
The First Affiliated Hospital of Air Force Medicial University
Intervention: Placebo Combined With Ursodeoxycholic Acid(drug)
Enrollment: 150 target
Eligibility: 18-75 years · All sexes
Timeline: 2023 – 2027

Study locations (7)

The second hospital of Lanzhou University, Lanzhou, Gansu, China
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China
The First Hospital of China Medical University, Shenyang, Liaoning, China
Ying han, Xi'an, Shaanxi, China
Sichuan Provincial People's Hospital,, Chengdu, Sichuan, China
Tianjin Medical University General Hospital, Tianjin, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05751967 on ClinicalTrials.gov

Other trials for Primary biliary cholangitis

Additional recruiting or active studies for the same condition.

See all trials for Primary biliary cholangitis →

← Back to all trials